GLP-1 medicines are not approved for managing period, hot-flash, or energy symptoms, and a changed period, new hot flashes, or persistent fatigue should be discussed with your doctor or licensed clinician especially if symptoms are severe, sudden, or could indicate pregnancy or another condition
This effect is mostly related to the dose, with higher doses generally creating more appetite suppression and weight loss
GIP also increases post-meal insulin and could aid fat metabolism
The cost to the Medicare enrollee depends on the tier at which the plan defines Ozempic
Although activation of the sympathetic nervous system may be involved in this response, the detailed mechanisms of action of GLP-1 receptor agonists are still not well understood